I too was very frustrated by the lack of communication from the company. Hoping and wishing to have some magical PR that garners approval from the FDA to help millions and millions of patients worldwide while the SP skyrockets. I’ve come to the realization that Missling is doing the best he can with what he has. Contrary to the belief of many on this board I don’t think “ we got this”, yet! I think that Missling is providing data as it comes while trying to navigate the processes with the FDA.
Avatar data will be crucial. Hopefully it shows those on higher doses of the drug do better. This will bode well for the excellence trial as well. Hopefully we get the full results of the PDD data as well and just maybe we get BTD. With that being said I am not holding my breath. As I said before I don’t think this is a miracle drug but I do believe it has the potential to help patients live a better life. That is why I am invested.
Market Data 
Markets 
AI
